Enterprise Diversion Compliance Director
About the job
- A Master’s degree or higher.
- At least 8 years of relevant experience in audit, investigation, compliance, or social sciences.
- At least 5 years of management experience.
- Ability to travel up to 25%.
- Lead the enterprise Medication Diversion Program and provide leadership and expertise in medication diversion prevention and controlled substance monitoring.
- Proactively manage medication triggers to provide a consistent approach to investigations and gap closures.
- Develop and memorialize drug diversion-related training and ensure ongoing regulatory compliance with Drug Enforcement Administration requirements.
- Own enterprise controlled substance compliance, controlled substance monitoring, and the Medication Diversion Program, including developing training, policies, and procedures to support medication compliance.
- Research and apply best practices to develop and drive innovative solutions across the company to decrease variation in the medication management process.
- Set and enforce consistent, safe, and effective approaches for diversion prevention and medication compliance.
- Lead the Corporate Medication Diversion Committee.
- Provide corporate oversight for controlled substance compliance with The Joint Commission, Centers for Medicare and Medicaid Services, U.S. Drug Enforcement Administration, Food and Drug Administration, and state and federal laws.
- Directly supervise the corporate medication diversion and compliance team.
- Lead the strategy for medication compliance audits at the facility level.
- Lead strategy with physician, nursing, ancillary, clinical leadership, informatics, Information Technology, pharmacy, safety, security, risk management, human resources, legal, communications, and compliance partners to assess, plan, develop, and implement a safe, effective, and reliable infrastructure for the drug diversion prevention program.
About the company
Ardent Health Services operates a network of acute care hospitals and outpatient facilities in mid-sized urban communities across the United States, earning revenue from patient services. It expands by forming joint ventures with non-profit health systems and academic medical centers, and by growing ambulatory and urgent care clinics to funnel patients into its network. It standardizes operations with a single Epic electronic health record to unify information and improve efficiency, supporting a coordinated care network. Its goal is to build a scalable, integrated health system that improves access and continuity of care in its communities.
Company Size
10,001+
Company Stage
Post IPO Equity
Headquarters
Brentwood, Tennessee
Founded
1993
Get referred to Ardent Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- Sept. 2, 2026 UT Tyler expansion deepens specialty capture and physician training.
- Aug. 4, 2026 cash flow hit $197 million, up 67% year over year.
- May 14, 2026 Fujifilm imaging deal tightens radiology and cardiology workflow.
What critics are saying
- Jan. 7, 2026 securities class action alleges inflated receivables and insurance reserves.
- Q2 2026 admissions fell 1.0%, and payor denials pressured revenue per admission.
- Medicaid supplemental payments fund revenue; cuts or redeterminations in 2026 crush EBITDA.
What makes Ardent Health unique
- Ardent’s 2018 UT System venture embeds care, training, and brand reach in East Texas.
- A single Epic platform standardizes hospitals and clinics across six states.
- Joint ventures with nonprofits anchor 18 of 30 hospitals, strengthening local referrals.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Paid Vacation
Tuition Reimbursement
Wellness Program
Remote Work Options
Growth & Insights and Company News
6 month growth
11%1 year growth
11%2 year growth
11%RBC Capital reaffirms their Buy rating on Ardent Health Partners, Inc. (ARDT). Oct. 8, 2026, 09:55 PM RBC Capital analyst Ben Hendrix maintained a Buy rating on Ardent Health Partners, Inc. on October 7 and set a price target of $13.00. The company's shares closed yesterday at $10.88. According to TipRanks, Hendrix is a 4-star analyst with an average return of 6.2% and a 51.71% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as HCA Healthcare, Cigna, and Universal Health. In addition to RBC Capital, Ardent Health Partners, Inc. also received a Buy from Truist Financial's David S Macdonald in a report issued on September 30. However, on September 23, BMO Capital initiated coverage with a Hold rating on Ardent Health Partners, Inc. (NYSE: ARDT). Based on Ardent Health Partners, Inc.'s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $1.62 billion and a net profit of $16.9 million. In comparison, last year the company earned a revenue of $1.65 billion and had a net profit of $72.95 million Read More on ARDT:
Cardiovascular Associates of America appoints Rebecca D. Holt as Vice President of Supply chai. Veteran healthcare leader brings more than 35 years of clinical, cardiovascular operations and enterprise supply chain experience to CVAUSA Becka brings an exceptional combination of clinical knowledge, operational experience and supply chain expertise that will be incredibly valuable as CVAUSA continues to grow" - Tim Attebery, CEO, CVAUSA ORLANDO, FL, UNITED STATES, September 16, 2026 / EINPresswire.com / - Cardiovascular Associates of America (CVAUSA), a physician-led cardiovascular organization dedicated to transforming cardiovascular care, today announced the appointment of Rebecca "Becka" D. Holt, MBA, RN, as Vice President of Supply Chain. Holt brings more than 35 years of healthcare leadership experience spanning clinical care, cardiovascular operations, supply chain, strategic sourcing, contracting, and value analysis. In her new role, she will lead CVAUSA's enterprise supply chain strategy, with a focus on leveraging the organization's scale, strengthening supplier partnerships, building scalable infrastructure, and supporting CVAUSA's continued growth and delivery of high-quality cardiovascular care. "Becka brings an exceptional combination of clinical knowledge, operational experience and supply chain expertise that will be incredibly valuable as CVAUSA continues to grow," said Tim Attebery, CEO, Cardiovascular Associates of America. "Her understanding of both the clinical and business sides of healthcare gives her a unique perspective on how supply chain strategy can support our physicians and practices while creating greater efficiency and value across the organization. We are incredibly pleased to welcome her to the CVAUSA leadership team." A Registered Nurse by training, Holt began her career in critical care and cardiovascular services before advancing into cardiovascular operations and enterprise supply chain leadership. Her clinical background has remained central to her leadership approach, enabling her to develop strategies that align the priorities of physicians, operations, and finance. Prior to joining CVAUSA, Holt served as Vice President of Supply Chain for Ardent Health, where she led enterprise supply chain strategy across a 30-hospital, multistate health system. Her career also includes leadership roles with AllSpire Health GPO, HealthTrust, and Wellmont Health System. "Joining CVAUSA is an exciting opportunity to bring together my clinical and supply chain experience in an organization that is focused exclusively on advancing cardiovascular care," said Holt. "As CVAUSA continues to expand, I look forward to developing a supply chain strategy and infrastructure that harnesses the strength of the organization, creates meaningful partnerships and supports physicians and practices in delivering exceptional care to their patients." In her role, Holt will work across CVAUSA and its partner practices to identify opportunities to leverage organizational scale, enhance strategic sourcing and contracting, strengthen vendor relationships and establish supply chain processes designed to support the organization as it continues to grow. About Cardiovascular Associates of America Cardiovascular Associates of America (CVAUSA) is a physician-led organization dedicated to transforming cardiovascular care by supporting independent cardiovascular practices with the resources, infrastructure and expertise needed to thrive in an evolving healthcare environment. Through its growing network of cardiovascular specialists and practices, CVAUSA works to improve access, quality, innovation, and outcomes while preserving physician leadership and clinical autonomy. Andrea morgan AM Consulting +1 917-213-5506 email us here Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
The only hospital in town: Ardent Health (ARDT) QAV America #69. This week QAV America dig into Ardent Health (ARDT), a regional hospital operator running about 30 facilities across six US states, currently cheap enough to earn a solid QAV score despite a messy couple of years that included a 34% single-day share price collapse, a CEO being shown the door, and a class action lawsuit. Tony and Cameron also wade into rising US bond yields, the headwinds facing the Mag Seven as their businesses go from capital-light to capital-heavy, and the genuinely alarming Hugging Face AI incident that has even Sam Altman talking about slowing down. This week's full episode is for QAV Club members only. The free episode is available below. Also check out its podcast archives link and its pages on Apple Podcasts or Spotify or watch clips on TikTok. Or visit its homepage to learn more about QAV and how it works as a value investing system that you can learn and apply to beat the market. Transcription. Previous pulled porks. Here's the performance of the "pulled porks" (eg deep dives) QAV America has done on the show in the past. 67 Deep dives since Mar 2025 +22.6% Average return per pick 67.2% Win rate (45 of 67) +202.8% Best pick (SSL) | Ticker | Company | Covered | Price then | Price now | Return | Ep. | | RJET | Republic Airways | 10 Aug 2026 | $21.39 | $17.44 | -18.5% | 65 | | BBDO | Banco Bradesco SA | 3 Aug 2026 | $3.44 | $3.16 | -8.1% | 64 | | RM | Regional Management | 27 Jul 2026 | $41.65 | $32.27 | -22.5% | - | | PBR | Petrobras | 20 Jul 2026 | $17.97 | $21.77 | +21.1% | 62 | | TEO | Telecom Argentina | 14 Jul 2026 | $13.47 | $13.94 | +3.5% | 61 | | FG | F&G | 7 Jul 2026 | $28.55 | $23.52 | -17.6% | 60 | | KSS | Kohl's | 1 Jul 2026 | $17.34 | $16.36 | -5.7% | 59 | | CARE | Carter Bankshare | 23 Jun 2026 | $31.00 | $31.19 | +0.6% | 58 | | AERO | Aeromexico | 18 Jun 2026 | $17.34 | $14.75 | -14.9% | 57 | | NRIM | Northrim Bancorp | 1 Jun 2026 | $24.71 | $26.00 | +5.2% | 55 | | MGA | Magna International | 27 May 2026 | $65.20 | $63.42 | -2.7% | 54 | | BWLP | BW LPG Limited | 18 May 2026 | $21.06 | $25.82 | +22.6% | 53 | | KNOP | Knot Offshore Partners Com Unt | 14 May 2026 | $10.78 | $11.25 | +4.4% | - | | GSL | Global Ship Lease | 13 May 2026 | $41.79 | $45.63 | +9.2% | - | | DB | Deutsche Bank | 4 May 2026 | $31.11 | $38.69 | +24.4% | 51 | | UEIC | Universal Electronics | 29 Apr 2026 | $4.25 | $5.08 | +19.5% | - | | OPRT | Oportun Financial Corp. 20 Apr 2026 | $5.88 | $7.86 | +33.7% | 49 | | PAGS | PagSeguro Digital | 13 Apr 2026 | $10.67 | $9.62 | -9.8% | 48 | | CVGI | Commerical Vehicle Group | 6 Apr 2026 | $3.56 | $2.97 | -16.6% | 47 | | PBI | Pitney Bowes | 30 Mar 2026 | $10.86 | $17.32 | +59.5% | 46 | | KODK | Eastman Kodak | 23 Mar 2026 | $7.83 | $9.19 | +17.4% | 45 | | GPRK | GeoPark | 17 Mar 2026 | $8.77 | $11.79 | +34.4% | 44 | | MUR | Murphy Oil | 9 Mar 2026 | $34.55 | $40.40 | +16.9% | 43 | | NBR | Nabor Industries | 3 Mar 2026 | $77.80 | $89.30 | +14.8% | 42 | | BFH | Bread Financial | 28 Feb 2026 | $70.86 | $107.65 | +51.9% | 41 | | SHG | Shinhan FInancial Group | 17 Feb 2026 | $69.83 | $82.63 | +18.3% | 40 | | EC | Ecopetrol | 3 Feb 2026 | $12.57 | $18.26 | +45.3% | 38 | | CHRD | Chord Energy Corporation | 24 Jan 2026 | $95.53 | $157.00 | +64.3% | 37 | | AMTD | AMTD IDEA Group | 20 Jan 2026 | $1.02 | $1.02 | -0.4% | 36 | | VLRS | Controladora Vuela Compania de Aviacion SAB de CV | 13 Jan 2026 | $9.45 | $6.33 | -33.0% | 35 | | TUSK | Mammoth Energy Services, Inc. 10 Jan 2026 | $2.45 | $3.04 | +24.1% | 39 | | XIFR | Xplr Infrastructure | 6 Jan 2026 | $10.17 | $11.04 | +8.6% | 34 | | AMCX | Amc Networks | 1 Jan 2026 | $9.52 | $12.19 | +28.0% | 33 | | ZD | Ziff Davis, Inc. 16 Dec 2025 | $36.48 | $59.21 | +62.3% | 32 | | VALE | Vale SA | 11 Dec 2025 | $12.90 | $14.47 | +12.2% | 31 | | AER | AerCap Holdings NV | 29 Nov 2025 | $131.82 | $138.32 | +4.9% | 30 | | KEP | Korea Electric Power Corporation | 29 Nov 2025 | $16.74 | $11.44 | -31.7% | 29 | | PCG | PG&E Corporation | 24 Nov 2025 | $15.67 | $13.15 | -16.1% | 28 | | CALY | Topgolf Callaway Brands Corp. 12 Nov 2025 | $10.60 | $15.09 | +42.4% | 27 | | CALM | Cal-maine Foods, Inc. 23 Oct 2025 | $94.56 | $74.39 | -21.3% | 25 | | AAL | American Airlines Group Inc. 20 Oct 2025 | $13.78 | $12.77 | -7.3% | 26 | | DCH | Dauch | 9 Oct 2025 | $6.16 | $6.10 | -1.0% | 24 | | CYH | Community Health Systems, Inc. 3 Oct 2025 | $3.01 | $2.97 | -1.3% | 23 | | MEOH | Methanex Corporation | 15 Sep 2025 | $39.81 | $64.47 | +61.9% | 21 | | SUZ | Suzano Inc. 1 Sep 2025 | $9.73 | $9.23 | -5.1% | 20 | | KE | Kimball Electronics, Inc. 26 Aug 2025 | $28.65 | $24.11 | -15.8% | 19 | | TITN | Titan Machinery Inc. 14 Aug 2025 | $18.98 | $24.27 | +27.9% | 18 | | GTN | Gray Media, Inc | 7 Aug 2025 | $4.42 | $4.78 | +8.1% | 17 | | SENEA | Seneca Foods Corporation | 30 Jul 2025 | $102.12 | $179.66 | +75.9% | 16 | | BHC | Bausch Health Companies Inc. 22 Jul 2025 | $6.32 | $5.67 | -10.3% | 15 | | SSL | Sasol Limited | 17 Jul 2025 | $4.99 | $15.11 | +202.8% | 14 | | ZEPP | Zepp Health Corporation | 11 Jul 2025 | $2.98 | $4.33 | +45.3% | 13 | | PKX | POSCO Holdings Inc. 1 Jul 2025 | $48.49 | $61.10 | +26.0% | 12 | | PDS | Precision Drilling Corporation | 27 Jun 2025 | $47.78 | $89.47 | +87.3% | 11 | | IX | Orix Corporation | 19 Jun 2025 | $21.00 | $39.69 | +89.0% | 10 | | JXN | Jackson Financial Inc. 11 Jun 2025 | $83.00 | $138.21 | +66.5% | 9 | | IHS | IHS Holding Limited | 30 May 2025 | $5.38 | $8.46 | +57.2% | 7 | | F | Ford Motor Company | 21 May 2025 | $10.80 | $13.50 | +25.0% | 6 | | ENIC | Enel Chile SA | 14 May 2025 | $3.97 | $4.29 | +8.1% | 5 | | CM | Canadian Imperial Bank Of Commerce | 8 May 2025 | $63.76 | $113.35 | +77.8% | 4 | | DAC | Danaos Corporation | 2 May 2025 | $82.47 | $159.59 | +93.5% | 3 | | CX | Cemex Publicly Traded Stock Corporation With Variable Capital | 28 Mar 2025 | $5.66 | $10.19 | +80.0% | 2 | | ZIM | Zim Integrated Shipping Services Ltd | 13 Mar 2025 | $17.97 | $29.57 | +64.6% | 1 | 4 more recent picks from the last 30 days are available to QAV America members - members hear every deep dive a month before it appears here. Become a member Returns exclude dividends and are measured from the price on the day each stock was covered on the show. Prices as of Tue 15 Sep 2026, 5:45 pm ET. Updated automatically. Not financial advice.
Ardent Health has expanded specialty care services into the new UT Tyler School of Medicine Building in Tyler, Texas, marking the first time patient services and physician training share a single facility in the region. The building houses women's health, pulmonary, orthopaedic, imaging and surgical care alongside the medical school. The expansion builds on Ardent's 2018 joint venture with The University of Texas System. Since then, Ardent has invested over $315 million in capital and grown the provider network to roughly 640 providers, a 116% increase. Graduate medical education has expanded from about 39 residents in 2018 to more than 270 today. UT Tyler's School of Medicine, which opened in 2023, has attracted students with strong local ties, with 90% of the current class connected to the region.
Ardent Health reported second-quarter 2026 results with total revenue of $1.62 billion and net income of $17 million. The healthcare provider posted adjusted EBITDA of $115 million, whilst admissions decreased 1.0% year-over-year, though adjusted admissions grew 2.5%. Operating cash flow reached $197 million, up 67% from the prior year. The company reaffirmed its full-year 2026 guidance, projecting total revenue between $6.4 billion and $6.7 billion and adjusted EBITDA of $485 million to $535 million. CEO Dave Caspers said second-quarter performance was impacted by lower surgeries and admissions but noted volumes improved following early June. The company expects its IMPACT programme to generate at least $70 million in savings for 2026, up from a previous estimate of $55 million.